Evidence map›Paper›PMID 42675078›Full record

ArticleNature communications2026

Dynamic balance of CRISPR-Cas immunity and resistance plasmid anti-immunity mediated by a bifunctional protein AcrIE10.

Waitang Tsui, Yang Yang, Chuning Wang, Dan Li, Yixin Zhang, Xiaoyu Zhao, Jingjing Wu, Ji Guo, Yihua Wang, Xiang Cheng and 5 more

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Waitang Tsui *Institute of Antibiotics, Huashan Hospital, Fudan University, and Key Laboratory of Clinical Pharmacology of Antibiotics, National Health Commission of the People's Republic of China, Shanghai, China.
Yang Yang *Institute of Antibiotics, Huashan Hospital, Fudan University, and Key Laboratory of Clinical Pharmacology of Antibiotics, National Health Commission of the People's Republic of China, Shanghai, China.
Chuning Wang *Institute of Antibiotics, Huashan Hospital, Fudan University, and Key Laboratory of Clinical Pharmacology of Antibiotics, National Health Commission of the People's Republic of China, Shanghai, China.
Dan Li *Institute of Antibiotics, Huashan Hospital, Fudan University, and Key Laboratory of Clinical Pharmacology of Antibiotics, National Health Commission of the People's Republic of China, Shanghai, China.
Yixin ZhangInstitute of Antibiotics, Huashan Hospital, Fudan University, and Key Laboratory of Clinical Pharmacology of Antibiotics, National Health Commission of the People's Republic of China, Shanghai, China.
Xiaoyu ZhaoInstitute of Antibiotics, Huashan Hospital, Fudan University, and Key Laboratory of Clinical Pharmacology of Antibiotics, National Health Commission of the People's Republic of China, Shanghai, China.
Jingjing WuState Key Laboratory of Genetics and Development of Complex Phenotypes, Department of Biochemistry and Biophysics, School of Life Sciences, Electron Microscopy Center, Fudan University, Shanghai, China.ORCID 0009-0005-8419-1936
Ji GuoState Key Laboratory of Genetics and Development of Complex Phenotypes, Department of Biochemistry and Biophysics, School of Life Sciences, Electron Microscopy Center, Fudan University, Shanghai, China.
Yihua WangState Key Laboratory of Genetics and Development of Complex Phenotypes, Department of Biochemistry and Biophysics, School of Life Sciences, Electron Microscopy Center, Fudan University, Shanghai, China.
Xiang ChengKey Laboratory of Synthetic Biology, CAS Center for Excellence in Molecular Plant Sciences, Institute of Plant Physiology and Ecology, Chinese Academy of Sciences, Shanghai, China.
Xuhang LiDepartment of Systems Biology, University of Massachusetts Chan Medical School, Worcester, MA, USA.ORCID 0000-0001-6071-9605
Oksana KotovskayaThe Center for Bio- and Medical Technologies, Moscow, Russia.ORCID 0009-0008-8905-2654
Artem IsaevThe Center for Bio- and Medical Technologies, Moscow, Russia.ORCID 0000-0002-9593-2745
Jinbiao MaState Key Laboratory of Genetics and Development of Complex Phenotypes, Department of Biochemistry and Biophysics, School of Life Sciences, Electron Microscopy Center, Fudan University, Shanghai, China. majb@fudan.edu.cn.ORCID 0000-0002-0232-1786
Minggui WangInstitute of Antibiotics, Huashan Hospital, Fudan University, and Key Laboratory of Clinical Pharmacology of Antibiotics, National Health Commission of the People's Republic of China, Shanghai, China. mgwang@fudan.edu.cn.ORCID 0000-0001-7682-5859

Funding

National Natural Science Foundation of China (National Science Foundation of China) 82402671National Natural Science Foundation of China (National Science Foundation of China) W2512095, 81991531, and 32471347Russian Science Foundation (RSF) 25-44-02137Science and Technology Commission of Shanghai Municipality (Shanghai Municipal Science and Technology Commission) 22410710300
6 · The paper itself

Abstract

Despite targeting by CRISPR-Cas system, antimicrobial resistance plasmids are prevalent in clinical isolates of carbapenem-resistant Klebsiella pneumoniae which represent a major public health threat. A stable co-existence of plasmids and CRISPR-Cas systems is mediated by anti-CRISPR (Acr) proteins. Here, we report that previously identified AcrIE10 encoded by a resistance plasmid combines two functions: it inhibits CRISPR immunity by directly binding Cas7* subunit through its Acr domain, and acts as an Acr-associated (Aca) protein that self-represses the transcription of Acr locus. AcrIE10 is an example of an Aca protein that utilizes N-terminal ribbon-helix-helix (RHH) domain to specifically recognize the inverted repeat (IR) region in its own promoter. Crucially, a dimerization of AcrIE10 dimers is required for the effective binding to the IR and self-repression, while stoichiometry-dependent interaction with Cas7* facilitates transition to de-repressed state. These findings elucidate molecular mechanisms by which AcrIE10 operates as a dual functionAcr-Aca protein to achieve a delicate balance between host CRISPR-Cas immunity and plasmid anti-defense.

Indexed as

Bacterial ProteinsCRISPR-Cas SystemsKlebsiella pneumoniaePlasmidsDrug Resistance, BacterialGene Expression Regulation, BacterialPromoter Regions, GeneticBacterial Proteins

Identifiers

PMID42675078
PMCPMC13530269

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.